Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge

Published:2022-09 Issue:9 Volume:12 Page:3529-3547
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Ji Longshan,Li Qian,He Yong,Zhang Xin,Zhou Zhenhua,Gao Yating,Fang Miao,Yu Zhuo,Rodrigues Robim M.,Gao Yueqiu,Li Man

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference189 articles.

1. MAFLD: a consensus-driven proposed nomenclature for metabolic associated aatty liver disease;Eslam;Gastroenterology,2020

2. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis;Younossi;Hepatology,2019

3. Pathogenesis of NASH: the impact of multiple pathways;Noureddin;Curr Hepat Rep,2018

4. Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges;Dufour;Gut,2020

5. Apoptosis signal-regulating kinase-1 as a therapeutic target in nonalcoholic fatty liver disease;Kefala;Expet Rev Gastroenterol Hepatol,2019

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fanlian Huazhuo Formula alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating autophagy and lipid synthesis signaling pathway;World Journal of Gastroenterology;2024-08-14

2. Polydatin: a potential NAFLD therapeutic drug that regulates mitochondrial autophagy through SIRT3-FOXO3-BNIP3 and PINK1-PRKN mechanisms - a network pharmacology and experimental investigation;Chemico-Biological Interactions;2024-08

3. Anthriscus sylvestris: An overview on Bioactive Compounds and Anticancer Mechanisms from a Traditional Medicinal Plant to Modern Investigation;Mini-Reviews in Medicinal Chemistry;2024-07

4. Chaihu Guizhi Ganjiang Decoction attenuates nonalcoholic steatohepatitis by enhancing intestinal barrier integrity and ameliorating PPARα mediated lipotoxicity;Journal of Ethnopharmacology;2024-05

5. A systematic, updated review of Xuezhikang, a domestically developed lipid-lowering drug, in the application of cardiovascular diseases;Acta Pharmaceutica Sinica B;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3